Eisai gets marketing approval from EC for LENVIMA

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada...

August 23, 2018 | Thursday | News
Tokyo to host Medtec Japan 2019

Asia's largest exhibition and conference dedicated to the Medical Device Design and Manufacturing industry, "Medtec...

August 22, 2018 | Wednesday | News
Shionogi submits NDA for INTUNIV

Shire plc has announced that its partner in Japan, Shionogi & Co., Ltd has submitted a New Drug Application (NDA) fo...

August 21, 2018 | Tuesday | News
Telix, Nihon collaborate on renal cancer imaging for Japanese market

Singapore – Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development o...

August 20, 2018 | Monday | News
Eisai, Merck get FDA approval for LENVIMA capsules to treat HCC

Eisai Inc. and Merck known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administrati...

August 17, 2018 | Friday | News
Medtronic introduces IN.PACT Admiral DCB in Japan

Dublin-based Medtronic has announced the commercial launch of the IN.PACT Admiral Drug-Coated Balloon (DCB) in Japan. I...

August 17, 2018 | Friday | News
Kaneka officially starts continuous manufacturing under GMP

Japan based Kaneka Corporation has installed continuous manufacturing equipment to be applied to pharmaceutical products...

August 14, 2018 | Tuesday | News
Kyowa Hakko Kirin announces results of Phase 3 trial of patients with Cutaneous T-cell Lymphoma

Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...

August 13, 2018 | Monday | News
A device to assist exact hemodialysis catheter placement

Researchers at Okayama University developed a supporting device for accurately placing hemodialysis catheters on kidney ...

August 10, 2018 | Friday | News
Takeda unite Ambys to treat serious liver disease

Takeda has entered into a $100 million partnership with newly-launched biotech Ambys Medicines to support its discovery ...

August 10, 2018 | Friday | News
Qiagen, SRL to accelerate launch of companion diagnostics

Qiagen N.V. has announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to p...

August 3, 2018 | Friday | News
Eisai to market anti-Obesity agent in China through CY Biotech

Eisai Co., Ltd. announced that it has entered into an agreement to grant exclusive development and marketing rights for ...

July 31, 2018 | Tuesday | News
Eisai, Merck gets U.S. FDA breakthrough therapy designation for LENVIMA

Eisai Co., Ltd. and Merck & Co., Inc. announced  that the U.S. Food and Drug Administration (FDA) granted Break...

July 31, 2018 | Tuesday | News
Japan to lead human trial using stem cell to treat Parkinson's

A team of researchers from Kyoto University, Japan has announced the world's first human trial using a kind of stem cell...

July 31, 2018 | Tuesday | News
SanBio Receives $20 Million Grant From CIRM

SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...

July 30, 2018 | Monday | News
Mylan, Fujifilm Kyowa Kirin Biologics declares positive CHMP opinion for Hulio

Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the European Medicines Agency's Committee for Med...

July 30, 2018 | Monday | News
Solasia Pharma announces approval of Sancusco in China

Japan's Solasia Pharma, a specialty pharmaceutical company based in Asia, has officially announced that Sancuso (Granise...

July 27, 2018 | Friday | News
Eisai, Biogen present Clinical study of Elenbecestat for Alzheimer's at AAIC 2018

Eisai Co., Ltd. and Biogen Inc. announced detailed results from a Phase II clinical study (Study 202) of the investigati...

July 26, 2018 | Thursday | News